Skip to main content
Premium Trial:

Request an Annual Quote

Dana-Farber Inks Research, Supply Deal for MorphoSys' Slonomics Tech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MorphoSys' AbD Serotec unit today announced a research and supply agreement to provide the Dana-Farber Cancer Institute with its Slonomics technology.

Under the terms of the deal, research tools using the technology will be placed in the laboratory of Wayne Marasco at Dana-Farber. The Department of Cancer Immunology and AIDS at the institute is conducting research to develop transient immunity against life-threatening viral infections as part of a project funded by the Defense Advanced Research Projects Agency of the US Department of Defense.

MorphoSys acquired the Slonomics technology from Sloning Biotechnology in October for $26.5 million. Slonomics is a synthetic biology technology that enables the construction of protein libraries.

AbD Serotec has preferred access to the rights to commercialize products resulting from the agreement.

Other financial terms were not disclosed.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.